Scd401, sp-selectin and sicam-1 plasma levels in nasopharyngeal carcinoma

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 3, 2009, Pages 513-516

  Li, Lei ^a   Li, Ping ^a   Yang, Yu Qiong ^a   Zhang, Hong ^a   Ai, Ping ^a   Wang, Feng ^a   Jiang, Yu ^a   Zou, Li Qun ^a   Yan, Xi ^a   Luo, Feng ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Nasopharyngeal carcinoma; Platelet activation; Soluble CD40 ligand; Soluble intercellular adhesion molecule 1; Soluble P selectin

Indexed keywords

CD40 LIGAND; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN;

ARTICLE; BLOOD; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; NASOPHARYNX TUMOR;

CD40 LIGAND; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; P-SELECTIN;

EID: 67649964184     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Pietravalle F. Lecoanet-Henchoz S, Blasey H. et al. Human native soluble CD40L is a biologocally active trimer, processed inside microsomes. J Biol Chem, 1996;271 (11) :5965-5967.
2. Freedman JE. CD40-CD40L and platelet function. Beyond hemostasis. Circulation Res, 2003;92 (9) :944-946.
3. Chen M. Geng JG. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp, 2006; 54 (2) : 75-84.
4. van de Stolpe A. van der Saag PT. Intercellular adhesion molecule-1. J Mol Med, 1996;74 (1) :13-33.
5. Huang GW, Nong HT, Yu QS, et al. Platelet aggregation in head and neck tumors in China. Laryngoscope, 1997;107 (8) : 1142-1145.
6. Nash GF, Turner LF, Scully MF, et al. Platelets and cancer. Lancet Oncol, 2002; 3 (7) :425-430.
7. Roselli M. Mineo TC, Bcesili S. et al. Soluble CD40 ligand plasma levels in lung cancer. Clin Cancer Res, 2004; 10 (2) : 610-614.
8. Younes A. Snell V. Consoli U. et al. Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemia. Br J Haematol, 1998;100 (2) :135-141.
9. Tong AW, Lapayoti M. Netto G. et al. The growth inhibitory effects of CD40 Ligand (CD154) and its endogenous expression in human breast cancer. Clin Cancer Res, 2001;7 (3) :691-703.
10. Wagner DD. The Weibel-Palade body: the storage granule for von Willebrand factor and P-selectin. Tbromb Haemost, 1993; 70 (2) :105-110.
11. Roselli M. Mineo TC, Martini F. et al. Serum concertrations of soluble selectins in patients with lung cancer. Int J Biol Markers, 2002;17 (1) :56-62.
12. Blann AD, Gurney D. Wadley M. et al. Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor. Blood Coagul Fibrinolysis, 2001; 12 (1) :43-50.
13. Haznedaroglu IC, Bebekli M. Ozcebe O. et al. Serum L-selectin and P-selectin levels in lymphomas. Haematologia, 2000;30 (1) :27-30.
14. Kovacs E. The serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble gpl30 (sgp130) in different tumor stage. Correlation between the two parameters in progression of malignancy. Biomedicine and Pharmacotherapy, 2005;59 (9) :498-500.